{"id":"https://openalex.org/W7160919082","doi":"https://doi.org/10.22541/authorea.15003194/v1","title":"Pharmacogenetic, drug-gene interaction, clinical, and sociodemographic determinants of frequent use of the healthcare system and its economic impact","display_name":"Pharmacogenetic, drug-gene interaction, clinical, and sociodemographic determinants of frequent use of the healthcare system and its economic impact","publication_year":2026,"publication_date":"2026-05-12","ids":{"openalex":"https://openalex.org/W7160919082","doi":"https://doi.org/10.22541/authorea.15003194/v1"},"language":"en","primary_location":{"id":"doi:10.22541/authorea.15003194/v1","doi":"https://doi.org/10.22541/authorea.15003194/v1","is_oa":false,"landing_page_url":"https://doi.org/10.22541/authorea.15003194/v1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5135951962","display_name":"Patricia Ojalvo-Guiberteau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Ojalvo-Guiberteau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012576193","display_name":"Levin Thomas","orcid":"https://orcid.org/0000-0003-1520-9598","observed_orcids":["https://orcid.org/0000-0003-1520-9598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Levin Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067466164","display_name":"Carmen Mata-Mart\u00edn","orcid":"https://orcid.org/0000-0002-1849-1093","observed_orcids":["https://orcid.org/0000-0002-1849-1093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmen Mata-Mart\u00edn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089239863","display_name":"Juan Antonio Villatoro-Garc\u00eda","orcid":"https://orcid.org/0000-0001-5752-7784","observed_orcids":["https://orcid.org/0000-0001-5752-7784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan-Antonio Villatoro-Garc\u00eda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110742741","display_name":"Carla Gonz\u00e1lez de la Cruz","orcid":"https://orcid.org/0009-0007-6787-7025","observed_orcids":["https://orcid.org/0009-0007-6787-7025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Gonz\u00e1lez de la Cruz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040629879","display_name":"Jes\u00fas Cobaleda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jes\u00fas Cobaleda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012675397","display_name":"A. Pijierro-Amador","orcid":"https://orcid.org/0000-0002-4845-8139","observed_orcids":["https://orcid.org/0000-0002-4845-8139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agust\u00edn Pijierro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087619129","display_name":"Eva Pe\u00f1as\u2010Lled\u00f3","orcid":"https://orcid.org/0000-0001-9478-3445","observed_orcids":["https://orcid.org/0000-0001-9478-3445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eva Pe\u00f1as-LLed\u00f3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025811853","display_name":"Adri\u00e1n LLerena","orcid":"https://orcid.org/0000-0002-5663-7081","observed_orcids":["https://orcid.org/0000-0002-5663-7081","https://orcid.org/0000-0003-1076-0743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian LLerena","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5663-7081","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.12070000171661377,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperpolypharmacy","display_name":"hyperpolypharmacy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-gene-interactions","display_name":"drug-gene interactions","score":0.8349999785423279},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyp2d6-inhibitors","display_name":"CYP2D6 inhibitors","score":0.7889999747276306},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.7649999856948853},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.7170000076293945},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5889999866485596},{"id":"https://openalex.org/keywords/chronic-disease","display_name":"chronic disease","score":0.7390000224113464},{"id":"https://openalex.org/keywords/sociodemographic-factors","display_name":"sociodemographic factors","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7538999915122986},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.7318999767303467},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.6132000088691711},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5835999846458435},{"id":"https://openalex.org/C20387591","wikidata":"https://www.wikidata.org/wiki/Q930752","display_name":"Specialty","level":2,"score":0.5189999938011169},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.49410000443458557},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4657999873161316},{"id":"https://openalex.org/C124306116","wikidata":"https://www.wikidata.org/wiki/Q2512965","display_name":"Ambulatory care","level":3,"score":0.4526999890804291},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.4124999940395355},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.4106999933719635},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4027000069618225},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.3986999988555908},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.39800000190734863},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.35760000348091125},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.32820001244544983},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3246999979019165},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.320499986410141},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.304500013589859},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3012000024318695},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2978000044822693},{"id":"https://openalex.org/C147021879","wikidata":"https://www.wikidata.org/wiki/Q3027971","display_name":"Decile","level":2,"score":0.28760001063346863},{"id":"https://openalex.org/C2779195980","wikidata":"https://www.wikidata.org/wiki/Q5691206","display_name":"Healthcare Cost and Utilization Project","level":3,"score":0.2727999985218048},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.271699994802475},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.26260000467300415}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22541/authorea.15003194/v1","doi":"https://doi.org/10.22541/authorea.15003194/v1","is_oa":false,"landing_page_url":"https://doi.org/10.22541/authorea.15003194/v1","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2171466783","https://openalex.org/W3213971853","https://openalex.org/W2885133533","https://openalex.org/W2065844121","https://openalex.org/W2530908606","https://openalex.org/W7204971692","https://openalex.org/W1974819161","https://openalex.org/W2736258806","https://openalex.org/W2014551664","https://openalex.org/W4398211689"],"abstract_inverted_index":{"Aim:":[0],"To":[1],"identify":[2],"demographic,":[3],"clinical,":[4,28],"pharmacogenetic,":[5],"and":[6,23,31,55,85,96,149,164,243],"drug-gene":[7],"interaction":[8],"determinants":[9],"of":[10,88,121,132,215,239],"frequent":[11,89,133,147,161,183,216,229],"healthcare":[12,25,44,62,76,122,193,217,230],"utilization":[13,63,101,134,231],"across":[14,27,72,135,195],"multiple":[15],"care":[16],"settings":[17,137],"in":[18,46,174,179,236,246],"a":[19,42,118,204],"genotyped":[20,51],"Spanish":[21],"population,":[22],"evaluate":[24],"costs":[26,102,194],"drug":[29,198,241],"treatment,":[30],"pharmacogenetic":[32],"strata.":[33],"Methods:":[34],"This":[35],"retrospective":[36],"study":[37],"included":[38],"804":[39],"patients":[40],"attending":[41],"primary":[43,78],"center":[45],"Badajoz,":[47],"Spain.":[48],"Participants":[49],"were":[50,91,103,172,188],"for":[52,117,223],"CYP2D6,":[53],"CYP2C19,":[54],"CYP2C9.":[56],"Frequent":[57,114],"use":[58,90],"was":[59,126,144,158,209],"defined":[60],"as":[61,203],"\u226590":[64],"th":[65],"percentile":[66],"over":[67],"the":[68,129,237],"preceding":[69],"five":[70,73],"years":[71],"settings:":[74],"global":[75,148],"system,":[77],"care,":[79],"outpatient":[80,150,165],"medical":[81,151,166],"specialties,":[82],"emergency":[83,162],"department,":[84],"hospitalizations.":[86],"Determinants":[87],"evaluated":[92],"using":[93,105],"bivariate":[94,175],"analyses":[95,176],"multivariable":[97,180],"logistic":[98],"regression.":[99],"Healthcare":[100,111],"estimated":[104],"public":[106],"tariffs":[107],"issued":[108],"by":[109],"Extremadura":[110],"Service.":[112],"Results:":[113],"users":[115],"accounted":[116],"disproportionate":[119],"share":[120],"visits":[123],"(27.6\u201369.4%).":[124],"Hyperpolypharmacy":[125,208],"associated":[127,145,159,189,211],"with":[128,146,160,190,212,219],"highest":[130],"odds":[131,139,214],"all":[136],"(adjusted":[138],"ratios:":[140],"5.50-16.55).":[141],"Chronic":[142],"disease":[143],"specialty":[152,167],"utilization.":[153,168],"Strong":[154],"CYP2D6":[155],"inhibitor":[156],"prescribing":[157,202],"department":[163],"CYP2C19":[169],"gene\u2013substrate":[170,197],"interactions":[171],"significant":[173],"but":[177],"not":[178],"models.":[181],"Among":[182],"users,":[184],"non-normal":[185],"CYP":[186],"phenotypes":[187],"higher":[191,213],"mean":[192],"most":[196],"interactions,":[199],"supporting":[200],"pharmacogenetic-guided":[201],"cost-reduction":[205],"strategy.":[206],"Conclusion:":[207],"consistently":[210],"utilization,":[218],"setting-specific":[220],"associations":[221],"observed":[222],"other":[224],"variables.":[225],"Pharmacogenetic":[226],"influence":[227],"on":[228],"may":[232],"become":[233],"clinically":[234],"relevant":[235],"context":[238],"substrate":[240],"exposure":[242],"warrant":[244],"validation":[245],"larger":[247],"cohorts.":[248]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-05-13T00:00:00"}
